The Facts About Navigent3's Oral Fluid Technology 1. Unmatched Quality - On-site device developed and manufactured in the United States
- Test strips developed specifically for oral fluid (not repackaged urine strips)
- Superior colloidal gold immunoassay technology
- Tests for parent drugs and certain specified metabolites
2. Superior, proven technology for measuring recent, on-the-job drug abuse - Results correlate well with blood (1)
3. Confirmation via GC(LC)/MS(/MS) The “Gold Standard” , TAT: 48 hrs. 4. Cannot be adulterated or substituted as specimen collection is observed 5. Detection Windows (Source: Quest Diagnostics 2008): 
Oral fluid testing technologies are going to become the gold standard for all workplace drug & alcohol testing. The less invasive nature of oral fluid POCT sample collection creates obvious benefits like ease-of-use, instant results, and avoids any dignity or gender issues. Beyond these obvious and convenient benefits, the most important benefits address the serious problems and voids in traditional testing practices. Specifically, oral fluid detects "recent-use" vis. historical use, and unlike urine-based testing, has no adulteration/sample substitution issues. The Ora Point™ is the premium oral fluid POCT device on the market today. It sets the industry standard for performance, quality,ease-of-use and dependability. Its advantages include:
- Screens for "RECENT USE"
- Screens for today's most abused illicit drugs (see Technical Information)
- Has NO known adulterates or substitutes
- Delivers results in minutes
- Is less invasive than tradition testing methods
- Has no gender or dignity issues
- Has complete and integral confirmatory testing at certified laboratories
- Has simple, complete and inexpensive training for administrators
| Comparison | Urine vs. Oral Fluid | | A comparison between a traditional lab-based urine drug test and the Ora Point oral fluid device. |
| DRUG | Marijuana | URINE | ORAL FLUID | | | SAMPLE
| Specimen Special handling Minimum volume "Shy bladder" | Hazardous Yes 30 ml Possible | Non-hazardous No 1 ml No | | | COLLECTION | Principle Collection side Collector Procedure | Intrusive Secured facility Specialist - Hrs. | Non-invasive Not required Non-specialist Min. | | | ADULTERATION | Observed collection Substituted sample Diluted sample Masking agents | No Possible Possible Possible | Yes No No No | | | TESTING | Screening Cut-off Confirmation Cut-off | EMIT/ELISA 50 nag/ml GC-MS/MS 15 nag/ml | Immunoassay 4 nag/ml GC-MS/MS 2 nag/ml | | | FINDINGS | Detection starts Detection ends
Basic compound Quality/property
Implication Blood-equivalent | Several hours Days/weeks
Metabolites Waste product
Recent use No | Few minutes 12-24 hours
Parent drug Psychoactive
Under influence Yes |
Laboratory based Oral Fluid Drug Screening Drug Screening Cutoff GC/MS Cutoff Amphetamine 10 ng/ml 2 ng/ml Barbiturates 40 ng/ml 2 ng/ml Benzodiazepines 10 ng/ml 2 ng/ml Cocaine 20 ng/ml 2 ng/ml Methadone 10 ng/ml 2 ng/ml Opiate 20 ng/ml 2 ng/ml Oxycodone 20 ng/ml 2 ng/ml PCP 10 ng/ml 2 ng/ml Propoxyphene 40 ng/ml 2 ng/ml THC (delta-9) 5 ng/ml 0.5 ng/ml |